Correlation Between Novo Nordisk and Braxia Scientific

Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and Braxia Scientific at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and Braxia Scientific into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Novo Nordisk AS and Braxia Scientific Corp, you can compare the effects of market volatilities on Novo Nordisk and Braxia Scientific and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of Braxia Scientific. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and Braxia Scientific.

Diversification Opportunities for Novo Nordisk and Braxia Scientific

-0.31

Correlation Coefficient

Novo Nordisk  Braxia Scientific

Very good diversification

The 3 months correlation between Novo and Braxia is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and Braxia Scientific Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Braxia Scientific Corp and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with Braxia Scientific. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Braxia Scientific Corp has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and Braxia Scientific go up and down completely randomly.

Pair Corralation between Novo Nordisk and Braxia Scientific

Considering the 90-day investment horizon Novo Nordisk AS is expected to under-perform the Braxia Scientific. But the stock apears to be less risky and, when comparing its historical volatility, Novo Nordisk AS is 5.12 times less risky than Braxia Scientific. The stock trades about -0.21 of its potential returns per unit of risk. The Braxia Scientific Corp is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  0.40  in Braxia Scientific Corp on September 23, 2024 and sell it today you would lose (0.20) from holding Braxia Scientific Corp or give up 50.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Novo Nordisk AS  vs.  Braxia Scientific Corp

Novo Nordisk AS

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Braxia Scientific Corp

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Braxia Scientific Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating basic indicators, Braxia Scientific reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Novo Nordisk and Braxia Scientific

The main advantage of trading using opposite Novo Nordisk and Braxia Scientific positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, Braxia Scientific can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Braxia Scientific will offset losses from the drop in Braxia Scientific's long position.

The idea behind Novo Nordisk AS and Braxia Scientific Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.